Company: XXII
Filing Date: 2025-06-20
Form Type: S-3
Source: 0001641172-25-015905
Chunk: 14

Company: 22nd Century Group, Inc.
Filing Date: 2025-06-20
Form: S-3
Chunk 14
---
 a limitation of liability such that no director or officer shall be personally liable to us or any of our stockholders to the fullest extent permitted by the NRS.

Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended (the “Securities Act”) may be permitted to directors, officers and controlling persons of ours under Nevada law or otherwise, we have been advised that the opinion of the SEC is that such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event a claim for indemnification against such liabilities (other than payment by us for expenses incurred or paid by a director, officer or controlling person of ours in successful defense of any action, suit, or proceeding) is asserted by a director, officer or controlling person in connection with the securities being registered, we will, unless in the opinion of our legal counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such indemnification by our company is against public policy in the Securities Act and will be governed by the final adjudication of such issue.

Nasdaq Capital Market Listing

Our common stock is listed on the Nasdaq Capital Market under the symbol “XXII.”

Transfer Agent and Registrar

The transfer agent and registrar for our common stock is Continental Stock Transfer & Trust Company, One State Street, 30 thFloor, New York, NY 10004-1561.

| 6 |

<div align='center'>Selling StockholderS</div>

This prospectus relates to the resale from time to time by the selling stockholders named in this prospectus under the caption “Selling Stockholders,” or the Selling Stockholders, of 8,588,811 shares of our common stock, par value $0.00001 per share, or the Shares, comprising up to (i) 4,851,913 shares of our common stock issuable upon the exercise of outstanding warrants issued in a private placement on October 24, 2024, (ii) 300,458 shares of our common stock issuable upon the exercise of outstanding Placement Agent Warrants issued in connection with a private placement on October 24, 2024 and (iii) 3,436,440 shares of our common stock issuable upon the exercise of outstanding warrants issued in a private placement on April 30, 2025. We are registering the shares of common stock in order to permit the selling stockholders to offer the shares